Pharma Consultant

Hunter Syndrome Market experiences a positive push as the pharma companies spot the untapped opportunities

Articles, Business Consultant, Pharma Consultant

The Hunter Syndrome Market is expected to grow with CAGR of 7.5% in the coming years in the 7MM. Occurring in approximately 1 in 100,000 to...

Read More

Is the cure for Duchenne Muscular Dystrophy in the pipeline?

Articles, Business Consultant, Pharma Consultant

The Duchenne Muscular Dystrophy Market Size (DMD Market) in the 7MM was found to be USD 266.06 Million in 2017, during the study period...

Read More

Is the cure for Huntington’s disease on the horizon?

Articles, Business Consultant, Pharma Consultant

Several promising new developments and novel treatment approaches are fuelling Huntington’s disease Market. Progressive neurological...

Read More

Overcoming the prevailing unmet needs in Beta-Thalassemia Market

Articles, Business Consultant, Pharma Consultant

The current Beta-thalassemia market is experiencing the emergence of gene therapies as a one-time cure for the patients. Beta thalassemia...

Read More

Novel mutation-targeting therapies in the horizon to relieve the global healthcare burden NSCLC poses

Articles, Business Consultant, DelveInsight's Oncology based Reports, Pharma Consultant

Non-small cell lung cancer market is anticipated to increase in the 7MM from USD 9,730 million in 2017 by 2030. Worldwide, cancer claimed...

Read More

In the race to fight SARS-CoV-2: Merck, ISB; ViiV; Genalyte gears up

Business Consultant, News, Notizia, Pharma Consultant

Merck has collaborated with the Seattle-based Institute for Systems Biology (ISB) to further study novel coronavirus SARS-CoV-2. The...

Read More
Close